Today’s Headlines – Independent News Aggregator – Monday 6/1/20

Business Headlines Health Politics Technology U.S. World

Residents Guard Entrance to Target Store, Chant “4 More Years!” and “USA! USA!”

 

Journalists Beaten, Robbed During Live Report on George Floyd Protests

 

“Most of You Are Weak”: Trump Blasts State Govs After Weekend of Rioting/Protests

 

Raleigh, NC Police Chief: You Are On Your Own – “I Will Not Put an Officer in Harm’s Way to Protect the Property Inside of a Building”

 

University of Alabama Professor Tweets Instructions to Rioters on How to Pull Down National Monuments

 

George Floyd’s Murder Deliberate, Designed to Set Off Race Riots – Mike Adams

 

Arizona Sues Google For Tracking Android Users Location Illegally it Says

 

Mitch McConnell: “Next Stimulus Bill Will Be the Last,” Final Decision to Be Made in About a Month

 

Woman Throws Firebomb into a Police Van in NYC During Protests, Charged With Attempted Murder

 

The Gov’t is Doing Much More Than Collecting Our Data for Investigation Only When it’s Needed – “Contact Chaining” Means We’re All Being Watched – Constantly

 

Where is Ghislane Maxwell, Jeffrey Epstein’s Longtime Associate?

 

George Floyd’s Brother: “My Brother Was About Peace…Don’t Tear Up Your Town”

 

Tensions Over Status Cause Run on Dollars in Hong Kong

 

NBA Star JR Smith Beats Up “White Boy” Protestor for Damaging His Truck (Warning: Graphic Language and Violence)

 

Rooting for the Downfall of America? Be Careful What You Wish For…

 

America’s Descent Into Chaos – “Purge” Message Blared as Cars are Torched

 

Egyptians Adopt Mask-Wearing Protocols, With Some Coercion From Authorities

 

Covid19 Losing Potency: “In Reality, the Virus Clinically No Longer Exists in Italy” – Top Italian Doctor

 

“USA Addicted to Quitting” – China Hits U.S. Over Cutting Off Spigot to WHO

 

Lockdowns in the First World Halt Money Flows to the Third World – By As Much As $100 Billion According to Citi

 

Gilead Trades Just Before Promising Findings of Anti-Covid Drug Remdesivir May Draw Regulatory Scrutiny

Join the discussion